Author headshot

Stephanie C. Viguers

Viguers is an Editorial Director at Healio. She joined the company in 2014, starting out as an Editorial Assistant. She spent 3 years as an Online Content Editor, covering news in Infectious Disease, and then served as a Features Editor, working on special projects for various medical specialties, including Hematology/Oncology, Cardiology, Rheumatology and Gastroenterology. She now leads the Primary Care and Women's Health specialties at Healio. 

 

Outside of work, Viguers enjoys spending time with her husband and three sons and relaxing on the beach in Ocean City, NJ. 

 

For more of her professional work, visit her LinkedIn profile.

Most recent by Stephanie C. Viguers

SPONSORED CONTENT
April 25, 2025
1 min watch
Save

VIDEO: AI may help deepen understanding of obesity phenotypes

NATIONAL HARBOR, Md. — AI is “up and coming” across health care, and obesity medicine is no exception, according to Angela Fitch, MD, FACP, MFOMA.

SPONSORED CONTENT
April 17, 2025
3 min watch
Save

‘Partners in crime’: Neurologists collaborate with PCPs to improve brain health

SAN DIEGO — Facing a workforce shortage and higher patient volumes, neurologists are looking for ways to collaborate with primary care providers to improve outcomes, according to speakers at the American Academy of Neurology Annual Meeting.

SPONSORED CONTENT
April 10, 2025
3 min read
Save

TEMPO trials: Fixed, flexible doses of tavapadon improve motor function in Parkinson’s

SAN DIEGO — Fixed and flexible doses of tavapadon significantly improved motor function compared with placebo in patients with Parkinson’s disease, according to a pair of phase 3 trials presented at the American Academy of Neurology annual meeting.

SPONSORED CONTENT
April 10, 2025
2 min read
Save

Pridopidine beneficial in subset of patients with Huntington’s

SAN DIEGO — Pridopidine had a positive effect on clinical progression, cognition and motor function in patients with Huntington’s disease who were not on antidopaminergic medications, according to a pre-specified analysis of the PROOF-HD trial.

SPONSORED CONTENT
April 08, 2025
2 min read
Save

Felix NeuroAI wristband improves essential tremor outcomes

SAN DIEGO — A peripheral nerve stimulator powered by AI and worn as a wristband improved essential tremor symptoms and patients’ ability to perform daily activities compared with a sham device, data from the TRANQUIL trial show.

SPONSORED CONTENT
April 08, 2025
2 min read
Save

ACCORD-2: AXS-05 delays relapse time to Alzheimer’s disease agitation

SAN DIEGO — AXS-05 was well-tolerated and significantly delayed the time to agitation relapse compared with placebo in patients with Alzheimer’s disease, according to phase 3 data from the ACCORD-2 trial.

SPONSORED CONTENT
April 07, 2025
2 min read
Save

Nightmares may increase risk for early death

SAN DIEGO — Frequent distressing dreams may accelerate biological aging and increase the risk for early death, defined by WHO as younger than 70 years, according to a speaker at the American Academy of Neurology Annual Meeting.

SPONSORED CONTENT
April 06, 2025
4 min watch
Save

Merit E. Cudkowicz, MD, MSc, receives lifetime award for ALS research: ‘I'm not done yet’

SAN DIEGO — The American Academy of Neurology honored Merit E. Cudkowicz, MD, MSc, FAAN, with its Lifetime Achievement Award for her extensive work in ALS research.  

SPONSORED CONTENT
March 11, 2025
3 min watch
Save

‘Coming to the clinic soon’: Top AAD takeaways from Joel M. Gelfand, MD, MSCE

ORLANDO — The American Academy of Dermatology annual meeting was packed with “massive advancements” across the field, Joel M. Gelfand, MD, MSCE, chief medical editor of Healio Dermatology, said.

SPONSORED CONTENT
March 10, 2025
2 min read
Save

New AAD President Susan C. Taylor, MD, will focus on ‘taking care of dermatologists’

ORLANDO — Outgoing American Academy of Dermatology President Seemal R. Desai, MD, FAAD, passed the torch to Susan C. Taylor, MD, FAAD, who said she will continue pushing efforts to unify the organization during “a time of great disruption.”